Occudo Quantitative Strategies’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,154
Closed -$493K – 881
2026
Q2
$493K Buy
5,154
+432
+9% +$39.3K 0.03% 509
2026
Q1
$394K Buy
+4,722
New +$472K 0.02% 534
2025
Q2
– Sell
-4,550
Closed -$238K – 767
2025
Q1
$238K Buy
+4,550
New +$256K 0.03% 525
2024
Q1
– Sell
-4,259
Closed -$202K – 890
2023
Q4
$202K Buy
+4,259
New +$179K 0.03% 647
2023
Q3
– Sell
-4,602
Closed -$220K – 1133
2023
Q2
$220K Buy
+4,602
New +$208K 0.02% 824

Other funds holding IRMD

Occudo Quantitative Strategies's IRMD Position: Q3 2026 in Review

Occudo Quantitative Strategies sold out of iRadimed (IRMD) in Q3 2026, closing a stake of 5,154 shares — an estimated $493K sold.

Occudo Quantitative Strategies first reported a position in IRMD in Q2 2023 and held it in 5 quarters. The position peaked at $493K in Q2 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Occudo Quantitative Strategies reported no remaining iRadimed position as of Q3 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,154 iRadimed shares in Q3 2026, an estimated $493K.
  • Occudo Quantitative Strategies first reported a position in iRadimed in Q2 2023 and held it in 5 quarters.
  • Occudo Quantitative Strategies's iRadimed position peaked at $493K in Q2 2026.
  • 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.